Morphic Holding Inc (MORF)
29.25
-3.20
(-9.86%)
USD |
NASDAQ |
May 17, 16:00
29.25
0.00 (0.00%)
After-Hours: 20:00
Morphic Shareholders Equity (Quarterly): 663.58M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 663.58M |
| December 31, 2023 | 697.02M |
| September 30, 2023 | 723.17M |
| June 30, 2023 | 729.36M |
| March 31, 2023 | 426.52M |
| December 31, 2022 | 349.12M |
| September 30, 2022 | 365.06M |
| June 30, 2022 | 387.99M |
| March 31, 2022 | 313.37M |
| December 31, 2021 | 336.70M |
| September 30, 2021 | 350.16M |
| Date | Value |
|---|---|
| June 30, 2021 | 347.91M |
| March 31, 2021 | 368.89M |
| December 31, 2020 | 145.20M |
| September 30, 2020 | 130.30M |
| June 30, 2020 | 114.92M |
| March 31, 2020 | 128.14M |
| December 31, 2019 | 140.92M |
| September 30, 2019 | 159.35M |
| June 30, 2019 | -65.98M |
| March 31, 2019 | 82.61M |
| December 31, 2018 | -52.55M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-65.98M
Minimum
Jun 2019
729.36M
Maximum
Jun 2023
340.58M
Average
348.51M
Median
Shareholders Equity (Quarterly) Benchmarks
| Keros Therapeutics Inc | 453.95M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 682.76M |
| Total Liabilities (Quarterly) | 19.18M |